A detailed history of Creative Planning transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 12,133 shares of SAGE stock, worth $69,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,133
Holding current value
$69,522
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$7.02 - $13.08 $85,173 - $158,699
12,133 New
12,133 $87,000
Q3 2023

Nov 16, 2023

BUY
$16.75 - $48.98 $1,675 - $4,898
100 New
100 $2,000
Q4 2019

Jan 30, 2020

SELL
$60.18 - $154.77 $176,447 - $453,785
-2,932 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$140.29 - $189.96 $51,767 - $70,095
369 Added 14.4%
2,932 $411,000
Q2 2019

Jul 26, 2019

BUY
$157.85 - $183.09 $46,407 - $53,828
294 Added 12.96%
2,563 $469,000
Q1 2019

Apr 24, 2019

BUY
$89.33 - $163.65 $6,163 - $11,291
69 Added 3.14%
2,269 $361,000
Q4 2018

Feb 01, 2019

BUY
$81.94 - $139.71 $180,268 - $307,362
2,200 New
2,200 $211,000
Q3 2018

Oct 25, 2018

SELL
$138.11 - $169.04 $185,067 - $226,513
-1,340 Closed
0 $0
Q2 2018

Jul 20, 2018

BUY
$140.36 - $175.76 $188,082 - $235,518
1,340 New
1,340 $210,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.